Influence of alpinia zerumbet essential oil in the kinesiotherapeutic treatment of patients with syndrome pyramidal
International Journal of Development Research
Influence of alpinia zerumbet essential oil in the kinesiotherapeutic treatment of patients with syndrome pyramidal
Received 19th July, 2017; Received in revised form 05th August, 2017; Accepted 27th September, 2017; Published online 10th October, 2017
Copyright ©2017, Janaína Farias Cândido et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Essential oil of Alpinia zerumbet (EOAz) demonstrated action to improve the spastic muscle contraction performance in patients with cerebral vascular disease. Stroke, Cerebral Palsy and Spinal Cord Injury part of in the Pyramidal Syndrome (PS) features muscle tone change. Purpose of this study was investigate contraction muscle quality in the treatment with EOAz and its with Kinesiotherapy association in the patients with Syndrome Pyramidal. This study is a Clinical trial type II, monocentric, prospective randomized parallel-group, with volunteers (N = 60) adults with spasticity. Modification of the Modified Ashworth Scale (MMAS), Surface Electromyography (sEMG) and Systemic Arterial Pressure (SAP) were evaluated, before and after application of essential oil (33%) in the dose 05mL/2Kg or 0,05mL/4Kgin cases oftetraparesis, hemiparesis or paraparesis during 10 days of procedures. Results showed significantly decrease spasticity in pathological legs during best muscle contraction (ANOVA or Kruskal-Wallis test, p<0,05). In conclusion, association of kinesiotherapy with EOAz demonstrates efficiency in improving muscle recruitment of people with spasticity who need to perform motor rehabilitation.
